Lanjuan Li
Impact in
- Biological Psychiatry top 0.05%
- Hepatology top 0.1%
Papers in
- Hepatology 219
- Hepatitis C virus research 69
- Liver Disease and Transplantation 69
- Liver physiology and pathology 61
-
- Clostridium difficile and Clostridium perfringens research 60
- Journals
- Scientific Reports (37 papers)PLoS ONE (25 papers)Frontiers in Microbiology (18 papers)BMC Infectious Diseases (14 papers)Nutrients (14 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lanjuan Li
869 papers receiving 38.1k citations
Hit Papers
Peers
Comparison fields: 5 of 207
- Biological Psychiatry 1.9k
- Hepatology 4.1k
- Molecular Medicine 2.3k
- Infectious Diseases 8.0k
- Epidemiology 9.0k
Countries citing papers authored by Lanjuan Li
This map shows the geographic impact of Lanjuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanjuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanjuan Li more than expected).
Fields of papers citing papers by Lanjuan Li
This network shows the impact of papers produced by Lanjuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanjuan Li. The network helps show where Lanjuan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lanjuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 28 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 23 | |
| 8 | 2024 | 32 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 41 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 12 | |
| 14 | 2021 | 32 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 7 | |
| 17 | 2019 | 25 | |
| 18 | 2017 | 220 | |
| 19 | 2016 | 16 | |
| 20 | 2014 | 9 |
About Lanjuan Li
Lanjuan Li is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Molecular Medicine and Pharmacology, having authored 888 papers that have together received 38.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (178 papers), Gut microbiota and health (166 papers), Hepatitis B Virus Studies (106 papers), Hepatitis C virus research (69 papers), Liver Disease and Transplantation (69 papers), Liver physiology and pathology (61 papers), Clostridium difficile and Clostridium perfringens research (60 papers) and Probiotics and Fermented Foods (55 papers). The work is most often cited by research in Biological Psychiatry (1.9k citations), Hepatology (4.1k citations), Molecular Medicine (2.3k citations), Infectious Diseases (8.0k citations) and Epidemiology (9.0k citations). Lanjuan Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zongxin Ling, Longxian Lv, Kaijin Xu, Hongcui Cao, Chenxia Hu, Baohong Wang, Haifeng Lu, Jifang Sheng, Mingfei Yao and Bing Ruan. Their work appears in journals such as Scientific Reports, PLoS ONE, Frontiers in Microbiology, BMC Infectious Diseases and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.